IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
Krönke, J, Kuchenbauer, F, Kull, M, Teleanu, V, Bullinger, L, Bunjes, D, Greiner, A, Kolmus, S, Köpff, S, Schreder, M, Mügge, L-O, Straka, C, Engelhardt, M, Döhner, H, Einsele, H, Bassermann, F, BargoLanguage:
english
Journal:
Leukemia
DOI:
10.1038/leu.2016.384
Date:
December, 2016
File:
PDF, 1.50 MB
english, 2016
File converter
More search results
More benefits 
